Karolinska University HospitalHässelby, Sweden
Consultant Rheumatologist, Professor in Rheumatology
1330: Certolizumab-pegol, Abatacept, Tocilizumab or Active Conventional Therapy in Early Rheumatoid Arthritis: 48 Week Patient-reported Outcomes of the NORD-STAR Trial
Monday, November 13, 20239:00 AM – 11:00 AM PT
Disclosure information not submitted.